Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 25 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

12%

3 trials in Phase 3/4

Results Transparency

0%

0 of 13 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
18(85.7%)
Phase 3
2(9.5%)
Phase 4
1(4.8%)
21Total
N/A(18)
Phase 3(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (25)

Showing 20 of 25 trials
NCT07138417Not ApplicableRecruiting

Compassion-Based Family Intervention for Adolescents

Role: lead

NCT05842291Not ApplicableSuspended

pBFS Guided High-dose rTMS Therapy for Treatment-Resistant Depression

Role: collaborator

NCT07518264Not ApplicableActive Not Recruiting

Efficacy and Underlying Mechanisms of Group-Based Natural Psychotherapy for Anxiety Disorder

Role: lead

NCT07317765Not ApplicableActive Not Recruiting

Research on New Methods and New Models of Rehabilitation Intervention for Cancer Patients Based on Exercise and Psychological Intervention

Role: lead

NCT06292156Not ApplicableCompleted

tACS Treatment for Cognitive Impairments in Methamphetamine Addicts

Role: lead

NCT06875479Recruiting

Validation of Five Seasons Sleep Tracking Mat for the Diagnosis of Obstructive Sleep Apnea

Role: collaborator

NCT06793176Completed

Vibraimage Technology for Detecting Depression in Psychiatric Outpatients

Role: collaborator

NCT05552014Not ApplicableRecruiting

Study on the Efficacy Mechanism of Natural Psychotherapy for Neurosis

Role: lead

NCT05842278Not ApplicableUnknown

The Dosage Effect of pBFS Guided rTMS Treatment for MDD

Role: collaborator

NCT05258123Not ApplicableCompleted

Ginkgo Biloba Extract in the Treatment of Schizophrenia

Role: lead

NCT04986124Unknown

Quality of Life in Chinese Working and School Age Population With MDD

Role: collaborator

NCT04055181Not ApplicableCompleted

Influence of rTMS on Symptoms and Cognitive Function in Patients With Psychiatric Disorders

Role: lead

NCT04076371Not ApplicableCompleted

The Treatment Efficacy of Combination Atypical Antipsychotics With Sertraline in Patients With Schizophrenia

Role: lead

NCT03774927Not ApplicableCompleted

High Frequency rTMS Treatment for Cognitive Impairments in Chronic Schizophrenia Patients

Role: lead

NCT02918825Not ApplicableCompleted

Long-acting Paliperidone Palmitate Injection and Olanzapine for Schizophrenia

Role: lead

NCT03290313Phase 4Unknown

Clinical Trial Scheme of Shu Gan yi Yang Capsule

Role: collaborator

NCT02873234Unknown

A Study of Chinese Medicine Treating Depression

Role: collaborator

NCT02192723Not ApplicableCompleted

A Randomized Double-blind Trial With 6 Antipsychotic Drugs for Schizophrenia

Role: lead

NCT01524380Not ApplicableCompleted

Ginkgo Biloba Extract for Schizophrenia

Role: lead

NCT01391390Not ApplicableCompleted

Melatonin Treatment for Tardive Dyskinesia in Schizophrenia

Role: lead